hipaa-mobile-health
Addresses HIPAA compliance for mobile health (mHealth) applications, wearable devices, and remote patient monitoring. Covers OCR guidance on mobile device PHI, FDA-regulated mobile medical applications, FTC Health Breach Notification Rule for non-HIPAA apps, BYOD policies, and encryption requirements for ePHI on mobile platforms. Keywords: mHealth, mobile health, HIPAA mobile, wearable, remote monitoring, BYOD, mobile device management, app privacy.
- License 许可
- Apache-2.0
- 最近更新
- 2026-03-17
- Stars
- ★ 336
- Forks
- 67
01 前言 Front Matter
- name
- hipaa-mobile-health
- license
- Apache-2.0
- metadata
- { "tags": "hipaa, mobile-health, mhealth, wearable, remote-monitoring, byod, mobile-device, app-privacy", "author": "mukul975", "domain": "privacy", "version": "1.0", "subdomain": "healthcare-privacy" }
- description
- Addresses HIPAA compliance for mobile health (mHealth) applications, wearable devices, and remote patient monitoring. Covers OCR guidance on mobile device PHI, FDA-regulated mobile medical applications, FTC Health Breach Notification Rule for non-HIPAA apps, BYOD policies, and encryption requirements for ePHI on mobile platforms. Keywords: mHealth, mobile health, HIPAA mobile, wearable, remote monitoring, BYOD, mobile device management, app privacy.
02 资源文件 4
- 资产文件assets/template.md4.2 KB
- 参考文档references/standards.md4.4 KB
- 参考文档references/workflows.md8.5 KB
- 脚本scripts/process.py8.9 KB
03 SKILL.md 正文
HIPAA Mobile Health — mHealth Privacy and Security
Overview
Mobile health (mHealth) encompasses the use of mobile devices, applications, wearable sensors, and remote patient monitoring systems to deliver healthcare services and manage health information. OCR has issued specific guidance on HIPAA compliance for mobile devices, recognizing that the proliferation of smartphones, tablets, and wearable health technology creates significant risks to the confidentiality, integrity, and availability of ePHI. The regulatory landscape intersects HIPAA (for covered entities and business associates), FDA regulation (for mobile medical devices/software as a medical device), and FTC jurisdiction (for consumer health apps not covered by HIPAA).
Regulatory Framework
HIPAA Security Rule — Mobile-Relevant Provisions
- §164.310(b): Workstation use — policies specifying the proper functions to be performed and the physical attributes of surroundings for workstations accessing ePHI (includes mobile devices)
- §164.310(c): Workstation security — physical safeguards for workstations accessing ePHI to restrict access to authorized users
- §164.310(d): Device and media controls — policies for receipt, removal, disposal, and re-use of hardware and electronic media containing ePHI
- §164.312(a)(1): Access control — unique user identification, emergency access procedure, automatic logoff, encryption and decryption
- §164.312(a)(2)(iv): Encryption and decryption (addressable) — encrypt ePHI stored on mobile devices
- §164.312(d): Person or entity authentication — verify identity of persons seeking access via mobile
- §164.312(e)(1): Transmission security — protect ePHI transmitted over wireless and cellular networks
OCR Mobile Device Guidance
OCR guidance emphasizes that the Security Rule applies to ePHI on all electronic media, including mobile devices. Key OCR positions:
- Mobile devices used to access, receive, transmit, or store ePHI must comply with Security Rule safeguards
- Lost or stolen unencrypted mobile devices containing ePHI constitute presumed breaches under the Breach Notification Rule
- The use of personal mobile devices (BYOD) does not exempt the entity from HIPAA compliance
FTC Health Breach Notification Rule (16 CFR Part 318)
For health apps and connected devices NOT covered by HIPAA:
- Applies to vendors of personal health records and related entities
- Expanded by FTC in 2023 to cover health apps, fitness trackers, and consumer wearables
- Requires breach notification to consumers, FTC, and (for 500+ individuals) media
- Violations subject to FTC enforcement (up to $50,120 per violation per day as of 2024)
FDA Mobile Medical Applications
- FDA exercises enforcement discretion for most general wellness and health management apps
- Software as a Medical Device (SaMD): FDA regulates apps that perform clinical decision support, diagnostic functions, or meet the definition of a medical device
- FDA does NOT enforce HIPAA but PHI handling in FDA-regulated devices must still comply with HIPAA
Mobile Device Security Requirements
| Requirement | Regulation | Implementation |
|---|---|---|
| Device encryption | §164.312(a)(2)(iv) | Full-disk encryption (AES-256) on all mobile devices accessing ePHI |
| Screen lock / auto-logoff | §164.312(a)(2)(iii) | Maximum 2-minute inactivity timeout; biometric or 6-digit PIN |
| Remote wipe capability | §164.310(d)(2)(iii) | MDM-enabled remote wipe for lost/stolen devices |
| Transmission encryption | §164.312(e)(1) | TLS 1.2+ for all data in transit; VPN for network access |
| App-level authentication | §164.312(d) | Per-app authentication for mHealth applications accessing ePHI |
| Malware protection | §164.308(a)(5)(ii)(B) | Mobile threat defense software; app vetting for sideloading |
| Audit logging | §164.312(b) | MDM audit trails for device access, app usage, data transfers |
| Data backup | §164.308(a)(7) | Automated backup of ePHI on mobile; exclude from consumer cloud backup |
BYOD Policy Requirements
For organizations permitting personal device use:
- Acceptable use policy: Define permitted PHI activities on personal devices
- MDM enrollment: Require mobile device management enrollment with containerization
- Separation of personal and work data: Use app-level containers or work profiles
- Minimum device standards: OS version requirements, jailbreak/root detection, encryption verification
- Offboarding: Remote wipe of organizational data upon termination; leave personal data intact
- Risk acceptance: Document that BYOD risk has been evaluated per §164.308(a)(1) risk analysis
Wearable and Remote Patient Monitoring
| Device Category | HIPAA Applicability | Key Privacy Considerations |
|---|---|---|
| Prescribed RPM devices (e.g., cardiac monitors) | Yes — CE or BA processes PHI | Encryption at rest and in transit; BAA with device vendor; patient consent for continuous monitoring |
| Provider-issued wearables (e.g., glucose monitors) | Yes — CE or BA processes PHI | Data minimization; defined retention; secure transmission to EHR |
| Consumer wearables (e.g., Fitbit, Apple Watch) | Only if data flows to CE/BA | FTC Health Breach Notification Rule applies if non-HIPAA; HIPAA applies once data enters CE/BA systems |
| Clinical trial wearables | Yes — research use of PHI | IRB oversight; authorization or waiver; de-identification at earliest opportunity |
Enforcement Examples
- Lifespan Health System (2020): $1.04 million — unencrypted stolen laptop; OCR found systemic failure to encrypt ePHI on mobile devices despite multiple prior incidents
- Children's Medical Center of Dallas (2017): $3.2 million — unencrypted BlackBerry lost in 2009 and unencrypted laptop stolen in 2013; OCR cited failure to implement encryption after risk analysis identified the risk
- CardioNet (2017): $2.5 million — stolen unencrypted laptop containing ePHI; OCR found insufficient risk analysis and device/media controls for mobile devices
Integration Points
- hipaa-security-rule: Mobile device requirements are a subset of Security Rule technical and physical safeguards
- hipaa-risk-analysis: Mobile devices must be included in enterprise risk analysis scope
- hipaa-breach-notification: Lost/stolen unencrypted mobile devices trigger breach assessment
- hipaa-employee-training: Workforce training must cover mobile device PHI handling
- hipaa-baa-management: BAAs required with MDM vendors, mHealth app vendors, and RPM device manufacturers that access PHI
04 同仓库更多 Skills
workplace-email-privacy
Implements email and internet monitoring compliance in the workplace per Barbulescu v Romania (ECHR Grand Chamber), EDPB guidance, and national labour law. Covers acceptable use policies, legitimate expectation of privacy, proportionality testing, and content vs metadata monitoring. Keywords: email monitoring, Barbulescu, workplace privacy, internet monitoring, acceptable use policy, ECHR, proportionality.
whistleblower-data
Implements data protection compliance for whistleblowing systems under EU Directive 2019/1937 and GDPR. Covers anonymous reporting channels, identity protection for whistleblowers and accused persons, retention limits, access restrictions, and retaliation prevention. Addresses national transpositions and DPA guidance. Keywords: whistleblower, Directive 2019/1937, anonymous reporting, identity protection, retaliation, retention, reporting channel.
vendor-termination-data
Vendor termination data return and deletion procedures per GDPR Article 28(3)(g). Covers data extraction formats, deletion certification requirements, transition planning, residual data handling, and post-termination verification.
vendor-risk-scoring
Vendor privacy risk tiering methodology for processor management. Covers scoring factors including data volume, sensitivity, transfer locations, certifications, breach history, and control maturity with weighted risk calculation and tier assignment.
vendor-privacy-due-diligence
Pre-contract vendor privacy due diligence per GDPR Article 28(1). Covers risk questionnaires, technical controls assessment, certification review, data flow analysis, and documented sufficiency decisions for processor engagement.
vendor-privacy-audit
On-site and remote vendor audit procedures per GDPR Article 28(3)(h). Covers audit planning, evidence collection methodologies, finding classification, remediation tracking, and audit report generation for processor compliance verification.